RDNT Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

515.46M

+8.04%

0.202

-8.33%

522.35M

+10.81%

-0.063

-81.91%

546.02M

+9.59%

0.237

-23.65%

Estimates Revision

The market is revising Upward the revenue expectations for RadNet, Inc. (RDNT) for FY2025, with the revenue forecasts being adjusted by 2.06% over the past three months. During the same period, the stock price has changed by -2.40%.

Revenue Estimates for FY2025

Revise Upward

+2.06%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-14.45%

In Past 3 Month

Stock Price

Go Down

-2.40%

In Past 3 Month

5 Analyst Rating

Wall Street analysts forecast RDNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RDNT is 79.25 USD with a low forecast of 71.00 USD and a high forecast of 92.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

0 Hold

0 Sell

Strong Buy

Current: 72.580

Low

71.00

Averages

79.25

High

92.00

Current: 72.580

Low

71.00

Averages

79.25

High

92.00

Barclays

Overweight

maintain

$79 -> $86

2025-11-13

Reason

Barclays

Price Target

$79 -> $86

2025-11-13

maintain

Overweight

Reason

Barclays raised the firm's price target on RadNet to $86 from $79 and keeps an Overweight rating on the shares following the investor day. The firm says the company's 2028 financial targets of 11%-13% revenue growth and 100-150 points of margin expansion support a mid-teens EBITDA growth outlook.

Truist

Buy

upgrade

$81 -> $90

2025-11-12

Reason

Truist

Price Target

$81 -> $90

2025-11-12

upgrade

Buy

Reason

Truist raised the firm's price target on RadNet to $90 from $81 and keeps a Buy rating on the shares. The firm is bullish on the stock following the company's upbeat Investor Day showcasing RadNet's broad capabilities and increasingly interconnected/integrated offerings, the analyst tells investors in a research note. RadNet is enviably positioned with strong demand and favorable overarching tailwinds, the firm added.

Barclays

Overweight

maintain

$60 -> $79

2025-09-03

Reason

Barclays

Price Target

$60 -> $79

2025-09-03

maintain

Overweight

Reason

Barclays raised the firm's price target on RadNet to $79 from $60 and keeps an Overweight rating on the shares following the Q2 report. The company's volume and productivity gains should build through fiscal Q1 of 2026, which creates a favorable share setup for the back half of 2025. It expects positive revisions to 2026 numbers.

Truist

Buy

maintain

$74 -> $81

2025-09-03

Reason

Truist

Price Target

$74 -> $81

2025-09-03

maintain

Buy

Reason

Truist raised the firm's price target on RadNet to $81 from $74 and keeps a Buy rating on the shares. The firm is bullish on the stock following its upbeat management meetings that highlighted robust core imaging center demand trends alongside a wide range of areas of opportunity for the company, supported by ongoing brisk investment in Digital Health, the analyst tells investors in a research note. RadNet is also well positioned to augment core trends via opportunistic M&A, Truist added.

B. Riley

NULL -> Buy

initiated

$69

2025-06-13

Reason

B. Riley

Price Target

$69

2025-06-13

initiated

NULL -> Buy

Reason

B. Riley initiated coverage of RadNet with a Buy rating and $69 price target.

B. Riley

Buy

initiated

$69

2025-06-13

Reason

B. Riley

Price Target

$69

2025-06-13

initiated

Buy

Reason

Valuation Metrics

The current forward P/E ratio for RadNet Inc (RDNT.O) is 113.44, compared to its 5-year average forward P/E of 80.81. For a more detailed relative valuation and DCF analysis to assess RadNet Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

80.81

Current PE

113.44

Overvalued PE

111.67

Undervalued PE

49.95

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

15.73

Current EV/EBITDA

20.72

Overvalued EV/EBITDA

19.33

Undervalued EV/EBITDA

12.12

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.52

Current PS

2.66

Overvalued PS

2.26

Undervalued PS

0.77

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 139.49% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

RDNT News & Events

Events Timeline

No data

News

8.0

12-15NASDAQ.COM

Significant Options Activity on Monday: CI, RDNT, SOFI

3.5

12-01Newsfilter

DeepHealth Launches AI-Powered Breast Suite, Boosting Detection Rates by 21%

5.0

12-01NASDAQ.COM

DeepHealth Introduces Advanced Imaging Informatics and Clinical AI Solutions at RSNA 2025

People Also Watch

Frequently Asked Questions

What is RadNet Inc (RDNT) stock price today?

The current price of RDNT is 72.58 USD — it has decreased -1.84 % in the last trading day.

What is RadNet Inc (RDNT)'s business?

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services in the United States. The Company has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. It provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. It is also a provider of AI-powered breast health solutions.

What is the price predicton of RDNT Stock?

What is RadNet Inc (RDNT)'s revenue for the last quarter?

RadNet Inc revenue for the last quarter amounts to 522.87M USD, increased 13.39 % YoY.

What is RadNet Inc (RDNT)'s earnings per share (EPS) for the last quarter?

RadNet Inc. EPS for the last quarter amounts to 0.07 USD, increased 75.00 % YoY.

What changes have occurred in the market's expectations for RadNet Inc (RDNT)'s fundamentals?

How many employees does RadNet Inc (RDNT). have?

RadNet Inc (RDNT) has 8546 emplpoyees as of December 16 2025.

What is RadNet Inc (RDNT) market cap?

Today RDNT has the market capitalization of 5.61B USD.